Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN
JPMorgan Chase & Co's stake in Regeneron Pharmaceuticals, Inc. fell to 4.40% (Schedule 13G/A)
Event May 30, 2025 · Filed Jun 5, 2025
JPMorgan Chase & Co's stake in Regeneron Pharmaceuticals, Inc. fell to 4.40%, 4,742,611 shares, as a passive investor on May 30, 2025. Filed Jun 5, 2025 (Schedule 13G/A).
- Stake
- 4.40%
- Shares
- 4,742,611
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO. | 4.40% | 4,742,611 |
Source
Related
- Regeneron Pharmaceuticals, Inc.
- JPMorgan Chase & Co
- Regeneron Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · JPMorgan Chase & Co · Apr 22, 2025
- Form 4 · Murphy Andrew J · Oct 15, 2026
- Form 4 · McCourt Marion · Sep 3, 2026
- Form 4 · Guarini Kathryn · Sep 3, 2026
- Form 4 · Larosa Joseph J · Aug 21, 2026
- Form 4 · Fenimore Christopher R. · Aug 20, 2026